Cutaneous Leishmaniasis Completed Phase Trials for Meglumine (DB09415)

Also known as: Leishmaniasis, Cutaneous / Cutaneous leishmaniasis (disorder)

IndicationStatusPhase
DBCOND0028439 (Cutaneous Leishmaniasis)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00469495Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous LeishmaniasisTreatment